Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
about
Clinical utility of eslicarbazepine: current evidence.Eslicarbazepine acetate as adjunctive therapy in patients with uncontrolled partial-onset seizures: Results of a phase III, double-blind, randomized, placebo-controlled trial.Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study.Eslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a randomized historical-control phase III study based in North AmericaEslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures.A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures.Safety Profile of Eslicarbazepine Acetate as Add-On Therapy in Adults with Refractory Focal-Onset Seizures: From Clinical Studies to 6 Years of Post-Marketing Experience.Eslicarbazepine Acetate Monotherapy: A Review in Partial-Onset Seizures.Eslicarbazepine acetate for the treatment of partial epilepsy.Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.Population pharmacokinetic modeling of oxcarbazepine active metabolite in Chinese patients with epilepsy.Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures.Analysis of oxcarbazepine and the 10-hydroxycarbazepine enantiomers in plasma by LC-MS/MS: application in a pharmacokinetic study.Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.Pooled efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: Data from four double-blind placebo-controlled pivotal phase III clinical studies.Eslicarbazepine acetate as adjunctive treatment in partial-onset epilepsy.Population Pharmacokinetic Evaluation and Missed-Dose Simulations for Eslicarbazepine Acetate Monotherapy in Patients With Partial-Onset Seizures.Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy.Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.A Pharmacokinetic Study Comparing Eslicarbazepine Acetate Administered Orally as a Crushed or Intact Tablet in Healthy Volunteers.Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers.
P2860
Q35087964-D52F5CCB-77C4-4827-84AE-ACC1C859C625Q35161125-213AAA7D-EC20-448D-A60D-0715ACA97BCEQ35424907-E485595B-2F17-4C67-BC18-34AF8F18EC4EQ35664957-F768DE14-CC6A-4C10-BF11-1900F8611975Q37243357-09B998C0-E2D0-4C53-82BF-133649FCDE7FQ37680030-08808501-3F26-443F-A983-16A6AE616818Q38223958-7FC630B5-75AF-4EF1-B125-5AE6B9483421Q38542064-8E6C9BA6-9423-4E66-B2F5-449CF0E73F9BQ38656011-6A1EC505-22A4-4885-B46A-3FB1FED8726CQ38800995-98E69CBF-9168-4D5A-94B4-14766FEB61B1Q38826584-E5CC04B0-9064-44B5-933F-A3D096D74EA4Q39456360-55E7F02C-CF63-4FBF-A977-AB232E285641Q41380075-947A8549-CE07-4360-81B6-6F4F39880DECQ44062629-844C8CB7-05E4-4240-ABC7-A8932D031A3FQ44168300-1557CA4C-E0F5-4A22-85FF-E1FF53E3A72BQ45172659-B78713B8-B836-47F0-9D80-D11586F45020Q47235722-1F19F39A-A86B-4BC9-89DB-B13369AB2D7AQ47797132-7D08A11A-AD7A-4C22-A96E-021F97CA07B5Q48352462-90426399-34FB-4E17-8C3A-6F1E7A059DD8Q50205952-57CB2702-CD4B-48A2-BAB7-871D7F5A12F8Q51736900-D3CE73EB-C000-4C50-BB14-1BF47EC56FEEQ53057610-F5679BC0-0AA7-4E30-A2FE-FE117BBF0FDFQ53156110-06B497A8-8E1E-4A28-897F-8295F4FF1207Q53301415-99278F71-ED6F-43C9-9F07-E2991C605540
P2860
Steady-state plasma and cerebrospinal fluid pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine in healthy volunteers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Steady-state plasma and cerebr ...... azepine in healthy volunteers.
@en
Steady-state plasma and cerebr ...... azepine in healthy volunteers.
@nl
type
label
Steady-state plasma and cerebr ...... azepine in healthy volunteers.
@en
Steady-state plasma and cerebr ...... azepine in healthy volunteers.
@nl
prefLabel
Steady-state plasma and cerebr ...... azepine in healthy volunteers.
@en
Steady-state plasma and cerebr ...... azepine in healthy volunteers.
@nl
P2860
P50
P1433
P1476
Steady-state plasma and cerebr ...... azepine in healthy volunteers.
@en
P2093
José Francisco Rocha
Teresa Nunes
P2860
P304
P356
10.1111/J.1528-1167.2012.03595.X
P577
2012-07-19T00:00:00Z